https://www.selleckchem.com/products/azd1656.html
Only one patient had valproate-induced hyperammonemic encephalopathy; however, many patients received treatment for hyperammonemia such as lactulose, levocarnitine, or VPA dose reductions. This study demonstrated variability in ammonia testing and management changes in SE but does not support the routine monitoring of ammonia levels and showed that hyperammonemic encephalopathy was rare in this clinical setting. This study demonstrated variability in ammonia testing and management changes in SE but does not support the routine monitorin
כמו
תגובה
לַחֲלוֹק
